Artiva Biotherapeutics, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-275872
- Form type
- 10-Q
- CIK
- 0001817241
- Primary document
- https://www.sec.gov/Archives/edgar/data/1817241/000119312525275872/artv-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Artiva Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $251,000 | - | - |
| Operating Income | $-67.9M | - | - |
| Net Income | $-63.1M | - | - |
| Eps Basic | -2.59 | - | - |
| Eps Diluted | -2.59 | - | - |
| Cash And Equivalents | $25.5M | - | - |
| Total Assets | $148.9M | - | - |
| Total Liabilities | $19.6M | - | - |
| Shareholders Equity | $129.2M | - | - |
| Operating Cash Flow | $-62.0M | - | - |
| Capital Expenditures | $2.2M | - | - |